7747N Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Steady Revenue GrowthConsistent multi-year revenue expansion indicates sustained demand for the company’s medical devices and components. Continued growth broadens the operating base, supports investment in product capabilities, and provides a durable foundation for earnings over the next several quarters.
Strong Profitability ImprovementHigh gross and operating profitability, together with the sharp 2026 net-margin improvement, suggests meaningful earnings power from the existing business. Strong margins can help fund innovation and expansion internally while providing resilience against moderate cost or demand pressure.
Conservative Balance SheetVery low leverage gives Asahi Intecc substantial financial flexibility and limits the burden of interest or refinancing obligations. A growing equity base combined with improved returns supports continued investment and reduces balance-sheet risk through normal business cycles.
Bears Say
Uneven Free Cash Flow HistoryRecent cash generation is solid, but the history of weak or negative free cash flow shows that earnings do not always convert consistently into deployable cash. This may constrain flexibility during weaker operating periods and makes sustained cash conversion an important execution test.
Bottom-line Earnings VolatilityThe large year-to-year change in net margin indicates that profitability can fluctuate even while revenue expands. Such volatility makes future earnings less predictable, potentially complicates long-term planning, and requires evidence that the 2026 improvement is sustainable.
Historically Moderate ReturnsThe recent ROE improvement is encouraging, but earlier moderate returns show that the company has not consistently generated its current level of capital efficiency. Maintaining stronger returns will depend on preserving profitability and converting growth into durable shareholder earnings.
Asahi Intecc Co News
7747N FAQ
What was Asahi Intecc Co Ltd’s price range in the past 12 months?
Currently, no data Available
What is Asahi Intecc Co Ltd’s market cap?
Asahi Intecc Co Ltd’s market cap is $103.54B.
When is Asahi Intecc Co Ltd’s upcoming earnings report date?
Asahi Intecc Co Ltd’s upcoming earnings report date is Nov 12, 2026 which is in 65 days.
How were Asahi Intecc Co Ltd’s earnings last quarter?
Asahi Intecc Co Ltd released its earnings results on Aug 14, 2026. The company reported $2.197 earnings per share for the quarter, beating the consensus estimate of $1.851 by $0.346.
Is Asahi Intecc Co Ltd overvalued?
According to Wall Street analysts Asahi Intecc Co Ltd’s price is currently same.
Does Asahi Intecc Co Ltd pay dividends?
Asahi Intecc Co Ltd does not currently pay dividends.
What is Asahi Intecc Co Ltd’s EPS estimate?
Asahi Intecc Co Ltd’s EPS estimate is 4.47.
How many shares outstanding does Asahi Intecc Co Ltd have?
Asahi Intecc Co Ltd has 265,332,300 shares outstanding.
What happened to Asahi Intecc Co Ltd’s price movement after its last earnings report?
Asahi Intecc Co Ltd reported an EPS of $2.197 in its last earnings report, beating expectations of $1.851. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Asahi Intecc Co Ltd?
Currently, no hedge funds are holding shares in MX:7747N
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Asahi Intecc Co Ltd
Asahi Intecc Co., Ltd. is a global enterprise dedicated to the research, manufacturing, and distribution of advanced medical devices. Its market reach extends across Japan, the United States, Europe, the Middle East, and China, with a significant international footprint. The company's diverse product range serves various medical specialties, including cardiology, where it supplies percutaneous transluminal coronary angioplasty (PTCA) guide wires, guiding catheters, balloon catheters, and penetration catheters. For peripheral, abdominal, and cerebrovascular systems, they provide specialized guide wires (including IVR guide wires and cerebrovascular system guide wires) and micro catheters. Additionally, Asahi Intecc produces guide wires and catheters vital for angiography procedures. Beyond its own brand, the company offers original equipment manufacturing (OEM) services for other medical device firms. It also manufactures a variety of medical and industrial components, such as element wires, stranded conductors, coils, tubes, and terminal processing products, specializing in the development and sale of ultra-fine stainless steel wire ropes and associated processed items. Founded in 1976 as Asahi Mini Rope Sales Co., Ltd., the company was renamed Asahi Intecc Co., Ltd. in July 1988 and is headquartered in Aichi, Japan.